Lv65
1610 积分 2023-06-06 加入
The Combination of Aztreonam-Avibactam in Multidrug-Resistant Gram-Negative Infections
22天前
已完结
Pharmacokinetics and safety of aztreonam/avibactam for the treatment of complicated intra-abdominal infections in hospitalized adults: results from the REJUVENATE study
22天前
已完结
Aztreonam-avibactam for carbapenem-resistant Gram-negative infections: Mechanisms, clinical efficacy, the challenge of resistance and susceptibility testing
22天前
已完结
Aztreonam-avibactam for the treatment of intra-abdominal infections
22天前
已完结
Aztreonam-avibactam versus meropenem for the treatment of serious infections caused by Gram-negative bacteria (REVISIT): a descriptive, multinational, open-label, phase 3, randomised trial
22天前
已完结
Aztreonam-Avibactam: A Review in the Treatment of Serious Bacterial Infections Caused by Aerobic Gram-Negative Organisms
22天前
已完结
Past, present, and future perspectives on aztreonam and avibactam
22天前
已完结
New β-Lactam/β-Lactamase Inhibitor Combination Antibiotics
22天前
已完结
Antimicrobial Resistance and New Antimicrobial Agents, A Review of the Literature
1个月前
已完结
Sulbactam-durlobactam for the treatment of Acinetobacter baumannii-calcoaceticus complex
1个月前
已完结
皖公网安备34019202002308
